Get the latest tech news
FDA To Use AI In Drug Approvals To 'Radically Increase Efficiency'
The FDA plans to use AI to "radically increase efficiency" in deciding whether to approve new drugs and devices, drawing on lessons from Operation Warp Speed to reduce review times to weeks. The plan was laid out in an article published Tuesday in JAMA. The New York Times reports: Another initiativ...
The FDA plans to use AI to "radically increase efficiency" in deciding whether to approve new drugs and devices, drawing on lessons from Operation Warp Speed to reduce review times to weeks. And officials want to speed up the final stages of making a drug or medical device approval decision to mere weeks, citing the success of Operation Warp Speed during the Covid pandemic when workers raced to curb a spiraling death count. For one, the model limits the number of characters that can be reviewed, meaning it is unable to do some rote data analysis tasks.
Or read this on Slashdot